4 ms·
I don't really get it. Why not just go with ketamine? Is it that the approval takes too much money which other companies could then reuse (the investement does
by LeanderK 7y ago
I don't really get it. Why not just go with ketamine? Is it that the approval takes too much money which other companies could then reuse (the investement does not lead to benefits)?
- wickoff 7y agoYes, that's exactly the reason. They are filtering racemic Ketamine just so that they can patent and upsell it at exorbitant rates.
- rocqua 7y agoCan the results be used ti justify off-label use of normal ketamine?
- wickoff 7y agoThere are hundreds of Ketamine clinics using it off-label already, the problem is that the insurance won't cover the off-label use and a course of about 10 infusions might cost around $5k at the current rates.
- navigatesol 7y ago>the problem is that the insurance won't cover the off-label use and a course of about 10 infusions might cost around $5k at the current rates. But I thought the goal of the pharmaceutical companies, according to your earlier comment, is to synthesize K to charge exorbitant prices. Aren't prices already exorbitant?
- wickoff 7y agoThe ketamine their are using costs a few bucks. Most of the money goes to the clinics for facilitating the treatments. Depending on the kind of session it can take about 2 hours and there are a few medical professionals involved. This cost stays, the cost of esketamine will be added on top.
- Taniwha 7y agoJust like Lunesta is filtered racemic Zopliclone (sold everywhere else)
- Nasrudith 7y agoVector of action is another reason - a nasal spray is far friendlier than injection. Although I don't know why that can't or shouldn't be done for ketamine.